Wolfgang Laux

About Wolfgang Laux

Wolfgang Laux is a senior employee representative and member of Sanofi’s Board of Directors, where he was appointed in April 2021 by the European Works Council. His profile is firmly rooted in industrial expertise and social governance, making him a distinctive figure within a global pharmaceutical group. He also serves on the Compensation Committee, a mandate that places him close to the Board’s work on executive pay, incentive structures, and talent attraction. Born on January 24, 1968, and German by nationality, Wolfgang Laux has worked for Sanofi and Aventis since 2000. Until 2006, he was a Senior Scientist in Process Development in Frankfurt/Höchst. He then moved into an industrial leadership role as Industrialization Coordinator for new products within the central Manufacturing & Supply organization in Croix-de-Berny and Gentilly. This career path shows long-standing involvement at the core of Sanofi’s industrial operations, with direct experience in process development, technology transfer, scale-up, and pharmaceutical manufacturing execution. His academic background reinforces that technical foundation. Wolfgang Laux holds a Ph.D. in organic chemistry from the University of Frankfurt am Main. He also completed post-doctoral research at the University of Montpellier and at the State University of New York at Stony Brook. In addition, he earned a Corporate Director’s Certificate from SciencesPo / IFA and the European Board Diploma from ecoDa, reflecting a deliberate effort to combine scientific depth with formal governance training. Since 2014, he has been active in employee representation through CFE-CGC. He has served on the Sanofi Chimie central works council, on the health, safety and working conditions committee (CHSCT) from 2016 to 2019, and as a union delegate since 2016. This experience gives him a concrete understanding of employee relations, working conditions, and the expectations of the workforce—issues that are increasingly central to listed-company governance. Sanofi has also quoted him publicly on the topic of living wage, where he emphasized the importance of defining the concept clearly and aligning action with purpose. Overall, Wolfgang Laux represents a hybrid governance profile at Sanofi: an experienced scientist, an employee representative, and a board member with a strong grasp of industrial transformation, compensation oversight, and social responsibility. His presence strengthens the bridge between corporate strategy, operational realities, and the voice of employees.